Regado Biosciences' REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and H... (gioplastydilatation and stenting in pati...)

Regado Biosciences' REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis

Date:5/14/2008

gioplasty dilatation and stenting in patients at low risk for complications associated with therapy-related bleeding or heart attack.

About REG1 Anticoagulation System

Regado's lead product candidate, REG1, is the first specific, direct-acting, antidote-controlled anticoagulant ever described. Regado is developing REG1 for use in patients suffering from acute coronary syndrome who undergo coronary revascularization procedures. These procedures, which include coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), put patients at a high-risk for therapy-related bleeding complications. REG1 is being developed initially to increase therapeutic flexibility and improve patient outcomes in coronary revascularization procedures.

REG1 is a two-component system, consisting of an aptamer-based anticoagulant and its matched antidote. The REG1 anticoagulant component, RB006, is a single-stranded, nucleic acid aptamer. RB006 selectively and potently binds to and inhibits Factor IXa, a protein that is critical to blood coagulation. The antidote component, RB007, is a complementary nucleic acid that binds to and neutralizes RB006. The binding of RB007 to RB006 causes the predictable and rapid reversal of RB006 that allows the patient's blood to return to normal.

About Regado Biosciences

Regado Biosciences is pioneering a new therapeutic field with the discovery and development of drug:antidote systems. Regado's drug:antidote systems are designed to give physicians the ability to fine-tune the therapeutic effect desired for each patient and in each setting. A spin-out of the Department of Surgery at Duke University Medical Center, Regado was created to answer the therapeutic needs identified by its scientific founders.

The Company's proprietary platform technology enables the discovery of oligonucleotide-based drug-antidote pairs to any target protein. Regado initially is focusing its discovery and development e
'/>"/>

SOURCE Regado Biosciences
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference
2. Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference
3. YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR AEROLEF(TM) AT AMERICAN PAIN SOCIETY ANNUAL MEETING
4. Pressure BioSciences, Inc. to Discuss First Quarter 2008 Financial Results and Provide Business Update
5. Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors
6. Sangamo BioSciences Announces First Quarter Conference Call and Webcast
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results
8. Monogram Biosciences Announces First Quarter 2008 Financial Results Conference Call
9. Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference
10. YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR TWO OF ITS ANTI-CANCER DRUGS AT AACR ANNUAL MEETING
11. Raven biotechnologies Announces Collaboration With Monogram Biosciences to Advance Diagnostic Cancer Technologies

Post Your Comments:

(Date:12/11/2009)... - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY ) ... of Dr. Alan Warrander to the role of ... ,, "Dr. Warrander will be responsible for the ... said Dr. Brad Thompson, President and CEO of ... of a Phase 3 trial examining REOLYSIN in ...

(Date:12/10/2009)... Microban International, Ltd., the global ... partnered with Sharp Imaging and Information Company ... to incorporate it,s third generation silver-based antimicrobial ... into the calculator keys during manufacture, Microban ... of damaging bacteria on the keys. ...

(Date:12/10/2009)... NEW YORK, Dec. 10 With the economy ... Company, Wall Street,s largest, fastest-growing small cap equity research ... of unique investment opportunities within the micro cap market ... on January 11, 2010 at the Grand Hyatt ... cap companies are overlooked and undervalued by much of ...

(Date:12/10/2009)... flow measurement, control, and level solutions, announced that ... Level Product Manager effective November 30, 2009. He ... penetration of the level measurement products around the ... Corp, a manufacturer of building materials, where he ... will report to Brooks Instrument Vice President Tim ...

Breaking Biology Technology:Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2 Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3 Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology 2 Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2 Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2 Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3

[0] Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development [0] Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology [0] Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference [0] Brooks Instrument Appoints Mike Bayda as Global Level Product Manager

... webcast: , , What: Abbott,s exercise of its ... a subsidiary of Isis. Total acquisition price will be, ... December 17, 2008 at 8:30 a.m. ET / 5:30 a.m. PT, Where: ... Simply log onto our Web site listed, ...

... line with Jatropha World Asia 2009, scheduled 16-17 ... of interviews with top Jatropha decision makers have ... and answer session was held with Pradip Bhar, ... Magor Biofuel Limited. Offered by free download, this ...

... ... (PRWEB) December 17, 2008 -- Facilitating the entry of ... protocol analyzer, now updated to effortlessly examine not only the wireless ... modem, but also the interface between the device CPU and the ...

Other Biology Technology:Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences 2 Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels 2 Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels 3 Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels 4 Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment 2 Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment 3

Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment

(Date:12/14/2009)... Pa., Dec. 14 MODA Technology Partners, ... (EM), utility and product testing for the Pharmaceutical ... 3.0, the company,s third generation mobile data acquisition ... organizations to further automate their regulated manufacturing processes. ... capabilities: ,, Fully-Configurable Test Methods: ...

(Date:12/13/2009)... may help to engineer plants that take advantage of ... finding could help to engineer crops that take advantage ... carbon dioxide they need for photosynthesis through microscopic breathing ... molecule of the gas gained, they lose hundreds of ... tighten to save water when CO 2 is ...

(Date:12/13/2009)... New Haven, Conn.A team led by Yale University ... in whole blood for the first time. Their ... online publication of Nature Nanotechnology , could ... of cancer and other diseases. , ... Professor of Engineering & Applied Science, and Tarek ...

[0] MODA Announces Availability of Third Generation Mobile Data Acquisition Platform [0] Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops [0] Scientists use nanosensors for first time to measure cancer biomarkers in blood

... new strategy developed in the Neonatal and Infant Feeding ... infants and other newborns with severe swallowing difficulties learn ... appearing in the February issue of the Journal ... Children,s were able to help 15 out of 20 ...

... N.C. Duke University Medical System researchers have discovered ... provide a new approach for future smoking-cessation products. ... Oliveira-Maia, M.D., Ph.D., a postdoctoral fellow of the Duke ... explore both the peripheral taste pathways activated by nicotine, ...

... NEW YORK The Damon Runyon Cancer Research ... researcher John Rinn, PhD, has been awarded a 2009 ... made to early-career researchers who are using "novel approaches ... member of the faculty at the Broad Institute in ...

Other Biology News:Crib-side studies help struggling newborns go home without feeding tubes 2 Crib-side studies help struggling newborns go home without feeding tubes 3 Nicotine activates more than just the brain's pleasure pathways 2 BIDMC scientist John Rinn, Ph.D., receives Damon-Runyon Rachleff Innovation Award 2

Crib-side studies help struggling newborns go home without feeding tubes Nicotine activates more than just the brain's pleasure pathways BIDMC scientist John Rinn, Ph.D., receives Damon-Runyon Rachleff Innovation Award

Consists of 4 separate 100mM solutions (ATP,GTP,CTP and UTP pH 7.5) as sodium salts. 98% Pure by HPLC...

Collected from sexually mature, mixed sex, mixed breed cats. Physiochemical constituents are measured to ensure lot-to-lot consistency....

Tracker Datamatrix TRxD reads any 1D and 2D barcodes within 0.5 seconds....

Donor feline serum and plasma...

Biology Products:

NTP Set from Bioline Feline serum from Equitech-Bio Tracker Datamatrix TRxD from Micronic BV Donor feline Serum - 500mL from Biomeda Corporation

Regado Biosciences' REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and H...(gioplastydilatation and stenting in pati...)